Immunocompromised & Vaccinations: Strong Positive Effects
COVID-19 Vaccines Safe and Effective for Cancer Patients Undergoing Radiation Therapy, New Study Finds
Table of Contents
A recent literature review by Austrian experts, published in Vaccines (DOI: 10.3390/Vaccines13070715),offers reassuring news for cancer patients undergoing radiation therapy: COVID-19 vaccines are not only safe but also effectively build immunity in this vulnerable population. The study, which included co-authors from several European research institutions, analyzed 22 scientific studies published between 2021 and 2024 to assess the security, immunogenicity, and effectiveness of thes vaccines.
Vaccination Highly Tolerated with Mild Side Effects
The research team, led by Peter Thönen of the Department of Radio oncology at Linz/Merciful Sisters, found that COVID-19 vaccination was “overall tolerated and safe” for cancer patients receiving radiation. Side effects were infrequent and generally mild, offering peace of mind to both patients and their care teams.
This is especially important as cancer patients are often more susceptible to severe illness from infections like COVID-19, and may have concerns about adding another potential stressor to their treatment plan. The study’s findings directly address those concerns.
Strong Immune Response Observed in Majority of Patients
The study revealed encouraging results regarding the vaccines’ ability to stimulate an immune response. A notable 93% of cancer patients undergoing radiation therapy demonstrated a sufficiently protective immune response, indicated by the formation of antibodies.
even more promising, this protective response held steady at 90% for patients receiving both radiation and chemotherapy – a combination often associated with a more compromised immune system. This suggests the vaccines can overcome some of the immunosuppressive effects of cancer treatment.
Urgent Suggestion: Vaccination During Active Treatment
The researchers concluded that COVID-19 vaccines demonstrate “excellent security,immunogenicity and effectiveness” in patients receiving radiation therapy. They also noted a high level of willingness among patients to receive the vaccine.
In fact, the observed results were comparable to, and even better than, those seen in patients undergoing other cancer treatments like chemotherapy. Based on these findings, the team urgently recommends COVID-19 vaccination, even while patients are actively undergoing cancer treatment.
This study provides strong evidence supporting the importance of prioritizing COVID-19 vaccination for cancer patients. Protecting this vulnerable population is crucial, and these findings offer a clear path forward for ensuring their safety and well-being.